Related Experiment Videos
Age-associated increase in interleukin 6 in MRL/lpr mice
International Immunology
|March 1, 1991
Summary
Abnormal interleukin 6 (IL-6) expression increases with age in MRL/lpr mice, correlating with autoimmune disease development. This suggests IL-6 dysregulation plays a key role in MRL/lpr pathogenesis.
Area of Science:
- Immunology
- Molecular Biology
- Autoimmune Diseases
Background:
- Abnormal expression of interleukin 6 (IL-6) is implicated in autoimmune diseases and glomerulonephritis.
- MRL/lpr mice are a model for studying autoimmune conditions.
Purpose of the Study:
- To investigate the role of IL-6 in the pathogenesis of autoimmune disease in MRL/lpr mice.
- To characterize the expression pattern and regulation of IL-6 in MRL/lpr mice.
Main Methods:
- ELISA to measure serum IL-6 levels.
- RT-PCR to detect IL-6 mRNA expression in spleen and lymph nodes.
- Southern blot analysis to examine IL-6 gene structure.
Main Results:
- Serum IL-6 levels showed an age-associated increase in MRL/lpr mice, starting by 3 weeks of age and reaching 410 pg/ml by 30 weeks.
- IL-6 mRNA was detected in the spleen and lymph nodes of MRL/lpr mice from 8 weeks of age.
- IL-6 gene promoter and 3' untranslated regions were normal, suggesting transcriptional dysregulation.
Conclusions:
- Abnormal IL-6 expression is linked to the lpr gene and plays a significant role in the development of polyclonal B cell activation and glomerulonephritis in MRL/lpr mice.
- The findings highlight IL-6 as a potential therapeutic target for autoimmune diseases characterized by glomerulonephritis.